CalciMedica Inc.

11/05/2024 | Press release | Distributed by Public on 11/05/2024 14:09

Statement of Changes in Beneficial Ownership - Form 4

Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Sanderling Venture Partners VI Co Investment Fund LP
2. Issuer Name and Ticker or Trading Symbol
CalciMedica, Inc. [CALC]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
1300 S EL CAMINO REAL, SUITE 203
3. Date of Earliest Transaction (Month/Day/Year)
11/01/2024
(Street)
SAN MATEO, CA 94402
4. If Amendment, Date Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/01/2024 P 86,867 A $3.75 814,300 D
Common Stock 11/01/2024 P 877 A $3.75 22,479 I By Sanderling Ventures Management VI
Common Stock 946,744 I By Sanderling Venture Partners VI, LP
Common Stock 7,456 I By Sanderling VI Beteligungs GmbH & Co KG
Common Stock 8,884 I By Sanderling VI Limited Partnership
Common Stock 435,148 I By Sanderling Ventures VII, L.P.
Common Stock 114,260 I By Sanderling Ventures VII (Canada), L.P.
Common Stock 27,609 I By Sanderling Ventures VII Annex Fund, L.P.
Common Stock 30,292 I By Sanderling Ventures Management VII
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Sanderling Venture Partners VI Co Investment Fund LP
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO, CA 94402
X
Sanderling Ventures Management VI
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO, CA 94402
X
Sanderling VI Beteiligungs GmbH & Co KG
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO, CA 94402
X
Sanderling Venture Partners VI LP
1300 S. EL CAMINO REAL SUITE 203
SAN MATEO, CA 94402
X
Sanderling VI Limited Partnership
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO, CA 94402
X
Sanderling Ventures VII, L.P.
1300 S. EL CAMINO REAL
SUITE 203
SAN MATEO, CA 94402
X
Sanderling Ventures VII (Canada), L.P.
1300 S. EL CAMINO REAL SUITE 203
SAN MATEO, CA 94402
X
Sanderling Ventures VII Annex Fund, L.P.
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO, CA 94402
X
Sanderling Ventures Management VII
1300 S. EL CAMINO REAL SUITE 203
SAN MATEO, CA 94402
X

Signatures

Sanderling Venture Partners VI Co-Investment Fund, L.P., By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its General Partner 11/05/2024
**Signature of Reporting Person Date
Sanderling Ventures Management VI, By: /s/ Fred Middleton, Owner 11/05/2024
**Signature of Reporting Person Date
Sanderling VI Beteiligungs GmbH & Co. KG, By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its Managing Limited Partner 11/05/2024
**Signature of Reporting Person Date
Sanderling Venture Partners VI , L.P., By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, L.P., its General Partner 11/05/2024
**Signature of Reporting Person Date
Sanderling VI Limited Partnership, By: /s/ Fred Middleton, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its Investment General Partner 11/05/2024
**Signature of Reporting Person Date
Sanderling Ventures VII, L.P. , By: /s/ Fred Middleton, Managing Director of M4 Partners VII, LLC, its General Partner 11/05/2024
**Signature of Reporting Person Date
Sanderling Ventures VII Annex Fund, L.P., By: /s/ Fred Middleton, Managing Director of M4 Partners VII Annex, LLC, its General Partner 11/05/2024
**Signature of Reporting Person Date
Sanderling Ventures VII (Canada), L.P., By: /s/ D. Michael Dixon, President of Sanderling Ventures VII (Canada) GP Inc., General Partner of Sanderling Ventures VII (Canada) G.P., L.P, its General Partner 11/05/2024
**Signature of Reporting Person Date
Sanderling Ventures Management VII, By: /s/ Fred Middleton, Owner 11/05/2024
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.